Chris Hamby
Posts
Congress Presses Health Insurance Regulators on ‘Troubling’ Billing Tactics
Lawmakers are zeroing in on MultiPlan, a firm that has helped insurers cut payments while sometimes leaving patients with large bills.
Revenues Down and Stock Battered as Data Firm Faces Scrutiny
MultiPlan has helped big health insurers make billions by reducing reimbursements for medical bills, but its business model is now being questioned.
Help The Times Report on Optum-Controlled Doctor’s Offices
The Times wants to hear from patients and providers about medical practices affiliated with Optum, a subsidiary of UnitedHealth Group. Share your experience below.
Klobuchar Asks Regulators to Investigate MultiPlan Over Health Care Pricing
A data analytics firm has helped big health insurers cut payments to doctors, raising concerns about possible price fixing.
Health Insurers’ Lucrative Alliance That Drives Up Patient Bills: 5 Takeaways
A private-equity-backed firm has helped drive down payments to medical providers, drive up patients’ bills and earn billions for insurers.
Insurance Companies Reap Hidden Fees as Patients Get Unexpected Bills
A little-known data firm helps health insurers make more when less of an out-of-network claim gets paid. Patients can be on the hook for the...
In Battle Over Health Care Costs, Private Equity Plays Both Sides
As medical practices owned by private equity firms fuel overbilling, a payment tool also backed by such investors helps insurers boost their profits.
Federal Government Cuts Ties With Troubled Vaccine Maker
Emergent BioSolutions ruined millions of doses of Covid-19 vaccines. Now its $600 million deal is canceled.
U.S. Authorities Seek Documents From Troubled Covid Vaccine Manufacturer
Emergent BioSolutions, which ruined 75 million vaccine doses at its Baltimore plant, disclosed records requests from Congress and federal and state law enforcement agencies.